Comparisons of cardioprotective efficacy between fibroblast growth factor 21 and dipeptidyl peptidase-4 inhibitor in prediabetic rats
© 2017 John Wiley & Sons Ltd Aims: Comparative efficacy between fibroblast growth factor 21 (FGF21) and vildagliptin on metabolic regulation, cardiac mitochondrial function, heart rate variability (HRV), and left ventricular (LV) function is not known. We hypothesized that FGF21 and vildaglipt...
Saved in:
Main Authors: | Pongpan Tanajak, Piangkwan Sa-nguanmoo, Nattayaporn Apaijai, Xiaojie Wang, Guang Liang, Xiaokun Li, Chao Jiang, Siriporn C. Chattipakorn, Nipon Chattipakorn |
---|---|
Format: | Journal |
Published: |
2018
|
Online Access: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85023613689&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/47092 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Similar Items
-
Comparisons of cardioprotective efficacy between fibroblast growth factor 21 and dipeptidyl peptidase-4 inhibitor in prediabetic rats
by: Pongpan Tanajak, et al.
Published: (2018) -
Comparisons of cardioprotective efficacy between fibroblast growth factor 21 and dipeptidyl peptidase-4 inhibitor in prediabetic rats
by: Tanajak P., et al.
Published: (2017) -
Dipeptidyl peptidase-4 inhibitor enhances restoration of salivary glands impaired by obese-insulin resistance
by: Jitjiroj Ittichaicharoen, et al.
Published: (2018) -
Dipeptidyl peptidase-4 inhibitor enhances restoration of salivary glands impaired by obese-insulin resistance
by: Jitjiroj Ittichaicharoen, et al.
Published: (2018) -
Dipeptidyl peptidase-4 inhibitors and the ischemic heart: Additional benefits beyond glycemic control
by: Nipon Chattipakorn, et al.
Published: (2018)